Metraipolis › archive › dc_f50fbb95dcc8

Efficacy of Modified Upadacitinib Dosing in Pediatric Refractory IBD: A Case-Based Analysis — Europe PMC PMID:41007133

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41007133
DOI
10.3390/children12091268
License (as archived)
solo-consultazione
Archived
2026-11-09T20:21:01.060Z
SHA-256 of the archived text
4c1baa70906f0d7ba69c84ba06095a8849377fff442cc1adfd4f5fa3246cd328
Stable URL of this page
https://metraipolis.com/documento/dc_f50fbb95dcc8

How to cite

Efficacy of Modified Upadacitinib Dosing in Pediatric Refractory IBD: A Case-Based Analysis — Europe PMC PMID:41007133 — Europe PMC (en), https://europepmc.org/article/MED/41007133 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_f50fbb95dcc8 (Metraipolis archive dc_f50fbb95dcc8, sha256 4c1baa70906f0d7ba69c84ba06095a8849377fff442cc1adfd4f5fa3246cd328)
BibTeX
@misc{dcf50fbb95dcc8,
  title = {Efficacy of Modified Upadacitinib Dosing in Pediatric Refractory IBD: A Case-Based Analysis — Europe PMC PMID:41007133},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41007133},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_f50fbb95dcc8; sha256 4c1baa70906f0d7ba69c84ba06095a8849377fff442cc1adfd4f5fa3246cd328},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41007133. Agents can read the archived copy with the MCP tool read_document.